glp 1 for ms patients A Phase 2 trial just began testing whether a GLP-1 drug can slow brain shrinkage glp 1 drugs and multiple

Injectable is the only viable path

So rather than using the calories it normally gets from the food you eat, the body gets the energy it needs by releasing its stores of glycogen

Pen-sharing poses a risk for transmission of blood-borne pathogens Adverse Reactions Most common adverse reactions (incidence 5%) are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation, hypoglycemia in patients with T2D, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss Drug Interactions When initiating Wegovy , consider reducing the dose of concomitantly administered insulin secretagogues or insulin to reduce the risk of hypoglycemia

The desire for rapid results is understandable, but chronic conditions developed over months or years rarely resolve in weeks

doi: 10.1371/journal.pone.0125361 244